ESCALATING DOSES OF INTERFERON-A-2B AS A WAY TO IMPROVE RESPONSE TO INTERFERON

增加干扰素 A-2B 剂量以改善干扰素反应

• 批准号: 3763025
• 负责人: MITCHELL L SHIFFMAN
• 金额: --
• 依托单位: VIRGINIA COMMONWEALTH UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3763025
• 关键词: chronic disease /disorder; clinical trials; drug administration rate /duration; drug screening /evaluation; human subject; human therapy evaluation; interferon alpha; microorganism disease chemotherapy

To determine if increasing doses of interferon-a-2b (up to 20 mu TIW) will improve biochemical response on patients with chronic HCV and to define appropriate cost effective dosing.

确定是否增加干扰素-a-2b 的剂量（高达 20 mu TIW） 将改善慢性丙型肝炎患者的生化反应 确定适当的具有成本效益的剂量。